<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04288219</url>
  </required_header>
  <id_info>
    <org_study_id>2019P003234</org_study_id>
    <nct_id>NCT04288219</nct_id>
  </id_info>
  <brief_title>Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary Edema</brief_title>
  <official_title>Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary Edema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Himalayan Rescue Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trial of Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary
      Edema
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients in the Everest area will assessed for evidence of acute HAPE. Subjects will be
      randomized and assigned to standard care options or treatment with Non-Invasive Positive
      Pressure Ventilation.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>No masking will be done, as the CPAP device will be visible to both participants and investigators</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygen saturation</measure>
    <time_frame>Up to 4 hours</time_frame>
    <description>Displayed on pulse oximeter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ultrasonographic assessment of pulmonary edema</measure>
    <time_frame>Up to 4 hours</time_frame>
    <description>Quantification of B-lines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective rating of dyspnea</measure>
    <time_frame>Up to 4 hours</time_frame>
    <description>Based on Dypnea Severity Scale (DSS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>High Altitude Pulmonary Edema</condition>
  <condition>Non-Invasive Positive Pressure Ventilation</condition>
  <condition>Hypoxia</condition>
  <arm_group>
    <arm_group_label>Standard of Care Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous supplemental oxygen and nifedipine 30mg will be administered to patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Invasive Positive Pressure Ventilation Management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CPAP at 10mmHg with supplemental oxygen, as well as nifedipine 30mg will be administered to patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-Invasive Positive Pressure Ventilation</intervention_name>
    <description>Continuous positive airway pressure delivered by face mask at 10cmH2O</description>
    <arm_group_label>Non-Invasive Positive Pressure Ventilation Management</arm_group_label>
    <other_name>CPAP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nifedipine</intervention_name>
    <description>Nifedipine 30mg, Pharmacotherapy</description>
    <arm_group_label>Non-Invasive Positive Pressure Ventilation Management</arm_group_label>
    <arm_group_label>Standard of Care Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>supplemental oxygen</intervention_name>
    <description>supplemental oxygen</description>
    <arm_group_label>Standard of Care Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adults (age 18-80)

          -  Travel through Pheriche, Nepal

          -  Diagnosis of HAPE by symptoms, vital signs, and lung ultrasound

        Exclusion Criteria:

          -  History of chronic respiratory conditions (asthma, COPD, ILD)

          -  Concomitant pneumonia or aspiration, cardiomyopathy, congestive heart failure

          -  Kidney disease

          -  Neurologic disorder

          -  Cognitive disorder

          -  Temporary altered mental status

          -  Use of phosphodiesterase inhibitors or nifedipine prior to diagnosis of HAPE

          -  Age under 18 or over 80

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>N. Stuart Harris, MD, MFA</last_name>
    <phone>617-724-3290</phone>
    <email>nsharris@mgh.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Blair A Parry</last_name>
    <phone>617-724-4758</phone>
    <email>bparry@mgh.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Himalayan Rescue Association</name>
      <address>
        <city>Kathmandu</city>
        <country>Nepal</country>
      </address>
    </facility>
    <contact>
      <last_name>Brian Strickland, MD</last_name>
      <phone>+977 1-4440293</phone>
      <email>bstrickland@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Brian M Strickland, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Nepal</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 25, 2020</study_first_submitted>
  <study_first_submitted_qc>February 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2020</study_first_posted>
  <last_update_submitted>February 27, 2020</last_update_submitted>
  <last_update_submitted_qc>February 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>N. Stuart Harris MD MFA</investigator_full_name>
    <investigator_title>Chief, Division of Wilderness Medicine, Principal Investigator, Clinical Innstructor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Altitude Sickness</mesh_term>
    <mesh_term>Pulmonary Edema</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Edema</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nifedipine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

